CD40LG and coronary artery disorder: Plasma levels of IgM against the THRB328–345 unmodified and HNE-modified peptide in CAD patients with a stenosis rate >70% were significantly higher than HCs (p = 0.0003, p = 0.0002) and CAD patients with stenosis rate <30% (p = 0.00498, p = 0.00486).